AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Stock Jumps 0.8% – Should You Buy?

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) shares rose 0.8% during mid-day trading on Wednesday. The company traded as high as $12.16 and last traded at $12.00. 489,818 shares were traded during mid-day trading, a decline of 37% from the average daily volume of 782,133 shares. The stock had previously closed at $11.91.

AGF U.S. Market Neutral Anti-Beta Fund Price Performance

The company’s 50 day moving average is $12.10 and its 200 day moving average is $12.20. The stock has a market cap of $304.20 million, a price-to-earnings ratio of 17.67 and a beta of -0.65.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. CoreCap Advisors LLC acquired a new position in AGF U.S. Market Neutral Anti-Beta Fund during the second quarter worth about $36,000. Crescent Grove Advisors LLC acquired a new stake in shares of AGF U.S. Market Neutral Anti-Beta Fund in the first quarter valued at approximately $6,614,000. Bank of New York Mellon Corp grew its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 59.4% in the first quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock valued at $380,000 after purchasing an additional 10,146 shares during the last quarter. Worth Asset Management LLC increased its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 20.5% during the 1st quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock worth $425,000 after purchasing an additional 5,190 shares in the last quarter. Finally, PMV Capital Advisers LLC increased its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 14.0% during the 1st quarter. PMV Capital Advisers LLC now owns 246,621 shares of the company’s stock worth $3,443,000 after purchasing an additional 30,234 shares in the last quarter.

About AGF U.S. Market Neutral Anti-Beta Fund

(Get Free Report)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

Further Reading

Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.